Transaction in Own Shares

Summary by AI BETAClose X

Helios Underwriting Plc has purchased 23,935 of its ordinary shares between September 1st and September 4th, 2026, at prices ranging from 227.40p to 227.80p, with a weighted average price of 227.70p per share. These shares will be held in treasury, resulting in 76,040,011 ordinary shares in issue, of which 6,379,451 are held in treasury. The remaining 69,660,560 shares will serve as the denominator for shareholders calculating notification requirements under FCA rules.

Disclaimer*

Helios Underwriting Plc
08 September 2026
 

 08 September 2026
 HELIOS UNDERWRITING PLC
 ("Helios ", or the "Company")
 Transaction in Own Shares

Helios, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, the world's largest insurance market, announces it has purchased the following number of its Ordinary shares of 10p each through Peel Hunt LLP.

Date of purchase

01 September - 04 September 2026

Number of ordinary shares purchased:

23,935

Lowest price per share (pence):

227.40

Highest price per share (pence):

227.80

Weighted average price per day (pence):

227.70

The Company intends to place the purchased shares into Treasury.

Following the settlement of the purchased shares, the Company will have 76,040,011 Ordinary shares in issue of which 6,379,451 are held in Treasury.

The figure of 69,660,560 may be used by shareholders as the denominator for calculating whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The table below contains detailed information about the purchases made as part of the buyback programme which was announced by the Company on 09 April 2026 (the "Programme").

 Aggregate information:

Venue

Volume Weighted Average Price (p)

Aggregated Volume

Lowest price paid per share (p)

Highest price paid per share (p)

AIMX

227.70

23,935

227.40

227.80

 
 Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Peel Hunt on behalf of the Company as part of the Programme is detailed below:

Number of shares purchased

Transaction price (pence)

Venue

Date

Time of each trade

Transaction Reference Number

17,000

227.80

AIMX

01-09-2026

11:57:48

00198823533TRLO1

4,974

227.40

AIMX

01-09-2026

15:57:24

00198847496TRLO1

1,961

227.60

AIMX

02-09-2026

14:47:35

00198895694TRLO1

 
 For further information contact:

Helios Underwriting plc

 

Louis Tucker - Chief Executive Officer

+44 (0)20 3965 6441

Adhiraj Maitra - Director of Finance and Operations

+44 (0)20 3743 2114

Peel Hunt (Nomad, Broker and Financial Adviser)

 

Dan Webster / Andrew Buchanan / Martin Frowde

+44 (0)20 7418 8900

Singer Capital Markets (Joint Broker)

 

Charles Leigh-Pemberton / Russell Cook / James Todd

+44 (0)20 7496 3000

FTI Consulting

 

Ed Berry

+44 (0)7703 330 199

Christian Harte

+44 (0)7974 288 763

 
 About Helios

Helios provides a limited liability direct investment into the Lloyd's insurancemarket and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visit www.huwplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings